Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease

NCT01721655 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lung Disease
Bronchopulmonary Dysplasia

Interventions

DRUG: Spironolactone
DRUG: Placebo

Sponsor

West Virginia University Healthcare